Greeting #barracudaking et al:
The subtlties of heart conditions escape me, but for the sake of comparison, how far has Admedus' TAVR progressed in terms of getting approvals etc, on the road to market, compared to Jena Valve?Has Admedus reached the same or similar 'device designation'?
I'm sure the answers are somewhere in the announcement history, but if you could point out the relavant bits?
Time is so short.
Regards,
P
Opportunity in TMVR, page-15
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |